U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C7H5O3.Sr
Molecular Weight 361.85
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of STRONTIUM SALICYLATE

SMILES

[Sr++].OC1=CC=CC=C1C([O-])=O.OC2=CC=CC=C2C([O-])=O

InChI

InChIKey=BJTJYQIAHXROJC-UHFFFAOYSA-L
InChI=1S/2C7H6O3.Sr/c2*8-6-4-2-1-3-5(6)7(9)10;/h2*1-4,8H,(H,9,10);/q;;+2/p-2

HIDE SMILES / InChI
Molecular Formula C7H5O3
Molecular Weight 137.1128
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula Sr
Molecular Weight 87.62
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

1921
1468
Doses

Doses

DosePopulationAdverse events​
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Disc. AE: Nausea and vomiting, Nausea...
Other AEs: Diaphoresis, Diaphoresis...
AEs leading to
discontinuation/dose reduction:
Nausea and vomiting (2%)
Nausea (slight, 2%)
Nausea (marked, 1%)
Nausea (21%)
Other AEs:
Diaphoresis (marked, 3%)
Diaphoresis (slight, 3%)
Deafness (2%)
Tinnitus (marked, 2%)
Tinnitus (slight, 2%)
Deafness (1%)
Deafness (2%)
Deafness (1%)
Delirium (slight, 4%)
Delirium (marked, 1%)
Hyperactive delirium (1%)
Delirium (1%)
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
AEs

AEs

AESignificanceDosePopulation
Deafness 1%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Deafness 1%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Delirium 1%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Hyperactive delirium 1%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Deafness 2%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Deafness 2%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Nausea and vomiting 2%
Disc. AE
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Nausea 21%
Disc. AE
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Delirium marked, 1%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Nausea marked, 1%
Disc. AE
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Tinnitus marked, 2%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Diaphoresis marked, 3%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Tinnitus slight, 2%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Nausea slight, 2%
Disc. AE
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Diaphoresis slight, 3%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Delirium slight, 4%
1.3 g 1 times / hour multiple, oral
Dose: 1.3 g, 1 times / hour
Route: oral
Route: multiple
Dose: 1.3 g, 1 times / hour
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
unhealthy, 12-48
Health Status: unhealthy
Age Group: 12-48
Sex: M+F
Sources:
https://jamanetwork.com/journals/jama/article-abstract/435863
Sourcing

Sourcing

Vendor/AggregatorIDURL
ABI Chem
AC1L1VQ2
AHH Chemical co.,ltd
MT-58771
http://www.ahhchemical.com/product/MT-58771.html
ChemTik
CTK4J6200
Debye Scientific
DB-052150
http://www.debyesci.com/cas_526-26-1.html
Finetech
FT-0632294
http://www.finetechnology-ind.com/prod/detail/pub/526-26-1.html
MP Biomedicals
207228
NovoSeek
10682
PubChem
54684619
https://pubchem.ncbi.nlm.nih.gov/compound/54684619
Patents

Patents

07241460
1
20050013877
1
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:35:09 GMT 2025
Edited
by admin
on Mon Mar 31 17:35:09 GMT 2025
Record UNII
OGF9EV99TC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
STRONTIUM SALICYLATE
Systematic Name English
BENZOIC ACID, 2-HYDROXY-, STRONTIUM SALT (2:1)
Preferred Name English
Code System Code Type Description
RXCUI
2045402
Created by admin on Mon Mar 31 17:35:09 GMT 2025 , Edited by admin on Mon Mar 31 17:35:09 GMT 2025
PRIMARY
EPA CompTox
DTXSID10890499
Created by admin on Mon Mar 31 17:35:09 GMT 2025 , Edited by admin on Mon Mar 31 17:35:09 GMT 2025
PRIMARY
DAILYMED
OGF9EV99TC
Created by admin on Mon Mar 31 17:35:09 GMT 2025 , Edited by admin on Mon Mar 31 17:35:09 GMT 2025
PRIMARY
ChEMBL
CHEMBL2107280
Created by admin on Mon Mar 31 17:35:09 GMT 2025 , Edited by admin on Mon Mar 31 17:35:09 GMT 2025
PRIMARY
FDA UNII
OGF9EV99TC
Created by admin on Mon Mar 31 17:35:09 GMT 2025 , Edited by admin on Mon Mar 31 17:35:09 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-386-4
Created by admin on Mon Mar 31 17:35:09 GMT 2025 , Edited by admin on Mon Mar 31 17:35:09 GMT 2025
PRIMARY
CAS
526-26-1
Created by admin on Mon Mar 31 17:35:09 GMT 2025 , Edited by admin on Mon Mar 31 17:35:09 GMT 2025
PRIMARY
PUBCHEM
54684619
Created by admin on Mon Mar 31 17:35:09 GMT 2025 , Edited by admin on Mon Mar 31 17:35:09 GMT 2025
PRIMARY
Related Record Type Details
Structure of Salicylic acid
PARENT -> SALT/SOLVATE
Structure of STRONTIUM CATION
PARENT -> SALT/SOLVATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966